Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Hongye He,Feng Li,Rui Tang,Nianhong Wu,Ying Zhou,Yuting Cao,Can Wang,Li Wan,Yang Zhou,Hua Zhuang,Pan Li

DOI: https://doi.org/10.34133/bmr.0088

2024-10-07

Abstract:[This corrects the article DOI: 10.34133/bmr.0064.].

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Jiaojiao Hao,Zhenglin Li,Changlin Zhang,Wendan Yu,Zhipeng Tang,Yixin Li,Xu Feng,Yue Gao,Quentin Liu,Wenlin Huang,Wei Guo,Wuguo Deng

DOI: https://doi.org/10.62347/suki5933

2024-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 13 in vol. 7, PMID: 28123844.].
Erratum: Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction: Erratum.

Zhenxing Sun,Yuji Xie,Robert J Lee,Yihan Chen,Qiaofeng Jin,Qing Lv,Jing Wang,Yali Yang,Yuman Li,Yu Cai,Rui Wang,Zhengyang Han,Li Zhang,Mingxing Xie

DOI: https://doi.org/10.7150/thno.72333

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.43233.].
Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Bin Ma,Wenjia Guo,Meihui Shan,Nan Zhang,Binlin Ma,Gang Sun

DOI: https://doi.org/10.1515/biol-2022-0810

2023-12-16

Abstract:[This corrects the article DOI: 10.1515/biol-2020-0054.].
Erratum: Transcriptional Downregulation of Mir-4306 Serves As a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.

Zitong Zhao,Lin Li,Peina Du,Liying Ma,Weimin Zhang,Leilei Zheng,Bo Lan,Bailin Zhang,Fei Ma,Bo Xu,Qimin Zhan,Yongmei Song

DOI: https://doi.org/10.7150/thno.82636

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30701.].
Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Hongzhi Li,Weihua Yuan,Shufang Bin,Guang Wu,Panyuan Li,Min Liu,Jifeng Yang,Xiang Li,Kaiyan Yang,Haihua Gu

2022-01-01

American journal of cancer research

Abstract:[This corrects the article on p. 688 in vol. 10, PMID: 32195036.].
Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Hang-Ping Yao,Liang Feng,Sreedhar Reddy Suthe,Ling-Hui Chen,Tian-Hao Weng,Chen-Yu Hu,Eun Sung Jun,Zhi-Gang Wu,Wei-Lin Wang,Song Cheol Kim,Xiang-Min Tong,Ming-Hai Wang

DOI: https://doi.org/10.1186/s40425-019-0571-7

IF: 12.469

2019-01-01

Journal for ImmunoTherapy of Cancer

Abstract:Following publication of the original article [1], the author reported two errors in the authors affiliations:
Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum

Zitong Zhao,Lin Li,Peina Du,Liying Ma,Weimin Zhang,Leilei Zheng,Bo Lan,Bailin Zhang,Fei Ma,Bo Xu,Qimin Zhan,Yongmei Song

DOI: https://doi.org/10.7150/thno.82636

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30701.].

medicine, research & experimental
Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

DOI: https://doi.org/10.1177/17588359241290373

2024-10-21

Abstract:[This corrects the article DOI: 10.1177/17588359241267148.].
Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Hae Sang Park,Shinya Yokomizo,Haoran Wang,Sophia Manganiello,Hailey Monaco,Rose McDonnell,Hajin Joanne Kim,Jiyun Rho,Sung Ahn,Jason Gladstone,Harry Jung,Homan Kang,Kai Bao,Satoshi Kashiwagi,Hak Soo Choi

DOI: https://doi.org/10.34133/bmr.0036

2024-05-29

Abstract:[This corrects the article DOI: 10.34133/bmr.0002.].
Corrigendum to “XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer”

Wenjun Wang,Minzhang Guo,Xiaojun Xia,Chao Zhang,Yuan Zeng,Sipei Wu

DOI: https://doi.org/10.1155/2021/3030267

2021-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2017/5718968.].
Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients

Jun Tang,Rong Deng,Rong-Zhen Luo,Guo-Ping Shen,Mu-Yan Cai,Zi-Ming Du,Shan Jiang,Ming-Tian Yang,Jian-Hua Fu,Xiao-Feng Zhu

DOI: https://doi.org/10.1007/s10549-016-3703-5

2016-01-01

Breast Cancer Research and Treatment

Abstract:Erratum to: Breast Cancer Res Treat (2012),134:549–560,DOI 10.1007/s10549-012-2080-y. In the original publication of the article, Fig. 5c was published incorrectly. The authors apologize for this error and the correct Fig. 5c is given below.
Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Qiuqiang Chen,Gang Jia,Xilin Zhang,Wenxue Ma

DOI: https://doi.org/10.3389/fimmu.2024.1376045

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1332057.].

immunology
Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Jiangsheng Xu,Yunhua Liu,Yujing Li,Hai Wang,Samantha Stewart,Kevin Van der Jeught,Pranay Agarwal,Yuntian Zhang,Sheng Liu,Gang Zhao,Jun Wan,Xiongbin Lu,Xiaoming He

DOI: https://doi.org/10.1038/s41565-019-0417-y

IF: 38.3

2019-01-01

Nature Nanotechnology

Abstract:The Supplementary Information originally published with this Article was an older version, in which ‘IFN-γ’ was misspelled ‘INF-γ’ in Supplementary Fig. 9 and the β-Actin blot in Supplementary Fig. 13 was the wrong image. The Supplementary Information has now been replaced.
miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer: Erratum

Xiaomin Liu,Xianyi Wang,Binshu Chai,Zong Wu,Zhenyu Gu,Heng Zou,Hui Zhang,Yanli Li,Qiangling Sun,Wentao Fang,Zhongliang Ma

DOI: https://doi.org/10.7150/ijbs.86344

2023-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.70312.].
Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Ju Huang,Fengqiu Liu,Xiaoxia Han,Liang Zhang,Zhongqian Hu,Qinqin Jiang,Zhigang Wang,Haitao Ran,Dong Wang,Pan Li

DOI: https://doi.org/10.7150/thno.67168

IF: 11.6

2021-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.29569.].

medicine, research & experimental
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Xuan Yang,Yalong Wang,Junke Zhao,Hehui Rong,Yujun Chen,Mengting Xiong,Xiaoxing Ye,Shihui Yu,Haiyan Hu

DOI: https://doi.org/10.1016/j.apsb.2023.08.006

IF: 14.903

2023-01-01

Acta Pharmaceutica Sinica B

Abstract:[This corrects the article DOI: 10.1016/j.apsb.2022.06.009.].
Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”

Chenglin Han,Zilong Wang,Shuxiao Chen,Lin Li,Yingkun Xu,Weiting Kang,Chunxiao Wei,Hongbin Ma,Muwen Wang,Xunbo Jin

DOI: https://doi.org/10.1155/2021/9857803

2021-12-14

Oxidative Medicine and Cellular Longevity

Abstract:[This corrects the article DOI: 10.1155/2021/8851763.].

cell biology
Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study.

Xiaowen Ma,Yang Song,Kuo Zhang,Lei Shang,Yuan Gao,Wei Zhang,Xiaochang Xue,Huimin Jia,Jian Geng,Wei Zhou,Yazheng Dang,Enxiao Li,Xinyu Ti,Fulin Fan,Yingqi Zhang,Meng Li

DOI: https://doi.org/10.1038/srep46953

IF: 4.6

2018-01-01

Scientific Reports

Abstract:This corrects the article DOI: 10.1038/srep09918.

Erratum to "Ultrasound Controllable Release of Proteolysis Targeting Chimeras for Triple-Negative Breast Cancer Treatment"

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Erratum: Targeting NF-κB/AP-2β Signaling to Enhance Antitumor Activity of Cisplatin by Melatonin in Hepatocellular Carcinoma Cells.

Erratum: Myocardium-targeted transplantation of PHD2 shRNA-modified bone mesenchymal stem cells through ultrasound-targeted microbubble destruction protects the heart from acute myocardial infarction: Erratum.

Erratum to "BRCA1 subcellular localization regulated by PI3K signaling pathway in triple-negative breast cancer MDA-MB-231 cells and hormone-sensitive T47D cells"

Erratum: Transcriptional Downregulation of Mir-4306 Serves As a New Therapeutic Target for Triple Negative Breast Cancer: Erratum.

Erratum: Overcome trastuzumab resistance of breast cancer using anti-HER2 chimeric antigen receptor T cells and PD1 blockade.

Correction To: Therapeutic Efficacy, Pharmacokinetic Profiles, and Toxicological Activities of Humanized Antibody-Drug Conjugate Zt/g4-MMAE Targeting RON Receptor Tyrosine Kinase for Cancer Therapy

Transcriptional Downregulation of miR-4306 serves as a New Therapeutic Target for Triple Negative Breast Cancer: Erratum

Erratum to "Additional biomarkers for pathological complete response in triple negative breast cancer"

Erratum to "Bifunctional Tumor-Targeted Bioprobe for Phototheranosis"

Corrigendum to “XRRA1 Targets ATM/CHK1/2-Mediated DNA Repair in Colorectal Cancer”

Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Publisher Correction: Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer: Erratum

Nanosonosensitizers for Highly Efficient Sonodynamic Cancer Theranostics: Erratum

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Author correction to “Coordinated regulation of BACH1 and mitochondrial metabolism through tumor targeted self-assembled nanoparticles for effective triple negative breast cancer combination therapy” [Acta Pharmaceutica Sinica B 12 (2022) 3934–3951]

Erratum to “Berbamine Suppresses the Progression of Bladder Cancer by Modulating the ROS/NF-κB Axis”

Erratum: Recombinant Mutated Human TNF in Combination with Chemotherapy for Stage IIIB/IV Non-Small Cell Lung Cancer: A Randomized, Phase III Study.